Annual Total Expenses
$5.20 M
+$2.42 M+87.30%
01 December 2023
Summary:
Lipella Pharmaceuticals Common Stock annual total expenses is currently $5.20 million, with the most recent change of +$2.42 million (+87.30%) on 01 December 2023. During the last 3 years, it has risen by +$4.18 million (+410.12%). LIPO annual total expenses is now at all-time high.LIPO Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$1.46 M
+$507.20 K+53.27%
01 September 2024
Summary:
Lipella Pharmaceuticals Common Stock quarterly total expenses is currently $1.46 million, with the most recent change of +$507.20 thousand (+53.27%) on 01 September 2024. Over the past year, it has increased by +$280.20 thousand (+23.76%). LIPO quarterly total expenses is now -7.35% below its all-time high of $1.58 million, reached on 30 June 2023.LIPO Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LIPO Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +23.8% |
| 3 y3 years | +410.1% | +213.2% |
| 5 y5 years | - | - |
LIPO Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +410.1% | -7.3% | +213.2% |
| 5 y | 5 years | at high | +410.1% | -7.3% | +213.2% |
| alltime | all time | at high | +410.1% | -7.3% | +213.2% |
Lipella Pharmaceuticals Common Stock Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.46 M(+53.3%) |
| June 2024 | - | $952.20 K(-21.8%) |
| Mar 2024 | - | $1.22 M(+3.3%) |
| Dec 2023 | $5.20 M(+87.3%) | $1.18 M(-13.1%) |
| Sept 2023 | - | $1.36 M(-13.9%) |
| June 2023 | - | $1.58 M(+45.3%) |
| Mar 2023 | - | $1.08 M(+99.6%) |
| Dec 2022 | $2.77 M | $543.40 K(-23.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $712.60 K(-8.8%) |
| June 2022 | - | $781.10 K(+1.5%) |
| Mar 2022 | - | $769.80 K(+65.2%) |
| Dec 2021 | $2.18 M(+113.6%) | - |
| Dec 2021 | - | $466.00 K(-10.9%) |
| Sept 2021 | - | $522.90 K(+7.0%) |
| June 2021 | - | $488.80 K(-29.9%) |
| Mar 2021 | - | $697.40 K |
| Dec 2020 | $1.02 M | - |
FAQ
- What is Lipella Pharmaceuticals Common Stock annual total expenses?
- What is the all time high annual total expenses for Lipella Pharmaceuticals Common Stock?
- What is Lipella Pharmaceuticals Common Stock quarterly total expenses?
- What is the all time high quarterly total expenses for Lipella Pharmaceuticals Common Stock?
- What is Lipella Pharmaceuticals Common Stock quarterly total expenses year-on-year change?
What is Lipella Pharmaceuticals Common Stock annual total expenses?
The current annual total expenses of LIPO is $5.20 M
What is the all time high annual total expenses for Lipella Pharmaceuticals Common Stock?
Lipella Pharmaceuticals Common Stock all-time high annual total expenses is $5.20 M
What is Lipella Pharmaceuticals Common Stock quarterly total expenses?
The current quarterly total expenses of LIPO is $1.46 M
What is the all time high quarterly total expenses for Lipella Pharmaceuticals Common Stock?
Lipella Pharmaceuticals Common Stock all-time high quarterly total expenses is $1.58 M
What is Lipella Pharmaceuticals Common Stock quarterly total expenses year-on-year change?
Over the past year, LIPO quarterly total expenses has changed by +$280.20 K (+23.76%)